Skip to content

Font size: A- | A | A+

Investor.gov Logo for Print
Press Alt + shift + h then Enter to skip to secondary navigation. Mac users press Control + shift + h

Selected Press Releases

SEC Issues Bulletin On Risks Of Investing In Reverse Merger Companies

06/09/2011

The Securities and Exchange Commission today issued an Investor Bulletin outlining the risks of investing in companies that enter U.S. markets through so-called “reverse mergers.”Read more

Tenaris to Pay $5.4 Million in SEC's First-Ever Deferred Prosecution Agreement

05/17/2011

The Securities and Exchange Commission today entered into a Deferred Prosecution Agreement (DPA) with Tenaris S.A. in its first-ever use of the approach to facilitate and reward cooperation in SEC investigations.Read more

SEC Halts Ponzi Scheme by Co-Founder of China Voice Holding Corp.

04/29/2011

The Securities and Exchange Commission today announced that it has obtained a court order freezing the assets of China Voice Holding Corp., which trades in over-the-counter markets and has claimed to have a portfolio of telecommunications products and services in both the U.S. and China. The SEC alleges that China Voice's co-founder and his two associates are operating an $8.6 million Ponzi scheme and misusing its proceeds, in part, to help fund the company's operations.Read more

SEC Seeks Public Comment on Effective Investor Education Programs

04/19/2011

Washington, D.C., April 19, 2011 — The Securities and Exchange Commission today published on its website a request for public comment on the effectiveness of existing investor education efforts as part of a review mandated by the Dodd-Frank Wall Street Reform and Consumer Protection Act.Read more

SEC Charges FDA Chemist With Insider Trading Ahead of Drug Approval Announcements

03/29/2011

Washington, DC, March 29, 2011 – The Securities and Exchange Commission today charged a U.S. Food and Drug Administration (FDA) chemist with insider trading on confidential information about upcoming announcements of FDA drug approval decisions, generating more than $3.6 million in illicit profits and avoided losses.Read more